4.46
-0.02 (-0.45%)
| Penutupan Terdahulu | 4.48 |
| Buka | 4.47 |
| Jumlah Dagangan | 1,797,756 |
| Purata Dagangan (3B) | 1,502,908 |
| Modal Pasaran | 215,704,784 |
| Harga / Buku (P/B) | 0.910 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 Aug 2025 |
| EPS Cair (TTM) | -4.62 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.78% |
| Nisbah Semasa (MRQ) | 6.30 |
| Aliran Tunai Operasi (OCF TTM) | -147.29 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -68.80 M |
| Pulangan Atas Aset (ROA TTM) | -30.07% |
| Pulangan Atas Ekuiti (ROE TTM) | -65.94% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | CARGO Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 0.0 |
| Purata | -1.50 |
|
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 0.65% |
| % Dimiliki oleh Institusi | 101.53% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |